Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable/Metastatic Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04045691
What this trial is testing

Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment

Who this might be right for
Melanoma Stage IVMelanoma Stage III
Pierre Fabre Pharma GmbH 750
Testing effectiveness (Phase 2)Study completedNCT01107665
What this trial is testing

Pazopanib and Paclitaxel as First-Line Treatment for Subjects With Unresectable Stage III and Stage IV Melanoma

Who this might be right for
Stage III MelanomaStage IV MelanomaUnresectable Melanoma
University of California, Irvine 60
Testing effectiveness (Phase 2)Study completedNCT03620019
What this trial is testing

Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma

Who this might be right for
Melanoma Stage IiiMelanoma Stage IvMelanoma+2 more
UNC Lineberger Comprehensive Cancer Center 25
Early research (Phase 1)Study completedNCT02935790
What this trial is testing

Selective HDAC6 Inhibitor ACY-241 in Combination With Ipilimumab and Nivolumab

Who this might be right for
Malignant Melanoma
Celgene 1
Early research (Phase 1)Study completedNCT00091143
What this trial is testing

Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Providence Cancer Center, Earle A. Chiles Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT02902042
What this trial is testing

Encorafenib + Binimetinib + Pembrolizumab in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma

Who this might be right for
Malignant Melanoma
Prof. Dr. med. Dirk Schadendorf 16
Not applicableStudy completedNCT04911998
What this trial is testing

A Prospective Observational Study on Targeted Therapy for Unresectable or Metastatic BRAFV600E Mutant Melanoma Patients

Who this might be right for
Melanoma (Skin)Metastatic MelanomaBRAF V600 Mutation
Pierre Fabre Medicament 400
Early research (Phase 1)Study completedNCT01522664
What this trial is testing

DEDN6526A in Patients With Metastatic or Unresectable Melanoma

Who this might be right for
Malignant Melanoma
Genentech, Inc. 53
Testing effectiveness (Phase 2)UnknownNCT04472806
What this trial is testing

Maintenance Treatment of Toripalimab(JS001) in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma

Who this might be right for
Mucosal Melanoma
Fudan University 31
Testing effectiveness (Phase 2)Ended earlyNCT03241927
What this trial is testing

Pembrolizumab Effects on NK Cell Exhaustion in Melanoma (Merck NK-IIT)

Who this might be right for
Melanoma
Nina Bhardwaj 1
Early research (Phase 1)Study completedNCT00217542
What this trial is testing

Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaRecurrent Renal Cell CancerStage III Melanoma+2 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT05089370
What this trial is testing

Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma

Who this might be right for
Malignant Melanoma
University of Colorado, Denver 8
Testing effectiveness (Phase 2)Ended earlyNCT02203604
What this trial is testing

High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaStage IIIA MelanomaStage IIIB Melanoma+2 more
CINJRegulatory 9
Very early researchStudy completedNCT03655756
What this trial is testing

PDNA Intralesional Cancer Vaccine for Cutaneous Melanoma

Who this might be right for
Cutaneous Melanoma, Stage IIICutaneous Melanoma, Stage IV
TuHURA Biosciences, Inc. 7
Testing effectiveness (Phase 2)Study completedNCT00412828
What this trial is testing

A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Unresectable Stage III or Stage IV Melanoma
CuraGen Corporation 117
Testing effectiveness (Phase 2)UnknownNCT04521075
What this trial is testing

A Phase Ib Trial to Evaluate the Safety and Efficacy of FMT and Nivolumab in Subjects With Metastatic or Inoperable Melanoma, MSI-H, dMMR or NSCLC

Who this might be right for
Melanoma Stage IVUnresectable MelanomaNSCLC Stage IV
Ella Therapeutics Ltd 42
Early research (Phase 1)Study completedNCT01245556
What this trial is testing

Safety and Efficacy Study of BMS-908662 in Combination With Ipilimumab in Subjects With Advanced Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 8
Not applicableWithdrawnNCT03205722
What this trial is testing

The Effectiveness of Nivolumab Monotherapy as First-Line Therapy in Adults With Advanced Melanoma in Germany

Who this might be right for
Melanoma
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT00942162
What this trial is testing

Test the Benefit of a New Anti-cancer Treatment in Patients With Unresectable Advanced Melanoma

Who this might be right for
Melanoma
GlaxoSmithKline 125
Testing effectiveness (Phase 2)Study completedNCT00700882
What this trial is testing

Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Melanoma (Skin)
Eastern Cooperative Oncology Group 81
Next Page